Selection of OHCA Survivors for Cardiac Catheterization
All OHCA survivors with ST-elevation or new LBBB on post-ROSC ECG should undergo emergent cardiac catheterization, and selected comatose patients without ST-elevation but suspected cardiac etiology should also be considered for emergency catheterization, particularly if hemodynamically unstable. 1
Evidence Base for Current Recommendations
The recommendations for cardiac catheterization in OHCA survivors are not based on randomized controlled trials, but rather on observational studies and consensus expert opinion. 1 The 2010 International Consensus on CPR explicitly noted that evidence consisted of Level of Evidence 3 and 4 studies—observational case series demonstrating feasibility and association with improved outcomes. 1
Key Observational Evidence Supporting Guidelines
The 2015 International Consensus performed a meta-analysis of two observational studies (Bro-Jeppesen and Hollenbeck) involving 513 patients without ST-elevation, showing that early angiography reduced hospital mortality (OR 0.51,95% CI 0.35-0.73). 1 However, the task force acknowledged this represented "very-low-quality evidence" with significant selection bias. 1
Clinical Algorithm for Patient Selection
Immediate Emergency Catheterization (Within 2 Hours)
Definite Indications:
- ST-elevation on post-ROSC ECG (>80% will have acute coronary lesion) 1
- New left bundle branch block 1
Strong Consideration (Weak Recommendation):
- Comatose patients with suspected cardiac etiology without ST-elevation, especially if: 1
- Hemodynamically unstable
- Witnessed VF/pVT arrest
- Short duration of CPR
- No obvious non-cardiac cause
- Young age
Factors Influencing Decision in Non-ST-Elevation Cases
The European Resuscitation Council 2015 guidelines specify that clinicians should weigh: 1
- Patient age
- Duration of CPR
- Hemodynamic stability
- Presenting cardiac rhythm (VF/pVT vs. non-shockable)
- Neurological status on arrival
- Urine output and lactate clearance
- Perceived likelihood of cardiac etiology
Critical caveat: Comatose status should not be a contraindication to immediate catheterization. 1
Strength and Limitations of Evidence
What the Studies Actually Showed
The foundational observational studies demonstrated: 1
- Coronary angiography and PCI were feasible following ROSC
- Successful PCI versus no PCI was associated with improved ejection fraction and survival
- Survival varied dramatically (95-100%) in highly selected patients with witnessed VF arrests of short duration with STEMI and recovery of consciousness
The Selection Bias Problem
All studies without ST-elevation enrolled only comatose patients and involved physician discretion in selecting candidates for catheterization. 1 This creates substantial selection bias—physicians likely chose patients they believed would benefit most, making it impossible to determine true treatment effect. 1
The 2015 Consensus explicitly acknowledged this represents "a departure from most existing guidelines for the treatment of the general population of non-ST elevation ACS patients without OHCA." 1
Conflicting Evidence
One 2018 retrospective study of 507 OHCA survivors found that early coronary angiography (<3 hours) was not associated with reduced 30-day mortality compared to non-early invasive strategy (adjusted HR 0.69,95% CI 0.35-1.37, p=0.029), even in patients with ST-elevation or cardiogenic shock. 2 This contradicts the guideline recommendations but represents a single-center experience.
Another 2018 study found that early PCI (not just angiography) was what drove survival benefit—early catheterization without PCI showed no significant benefit after statistical adjustment. 3
Integration with Post-Arrest Care
Therapeutic hypothermia should not delay catheterization and can be safely combined with PCI. 1 The 2010 Consensus recommended starting hypothermia as early as possible, preferably before PCI initiation. 1
Do not delay catheterization for hemodynamic optimization—proceed to the cath lab while simultaneously managing hypotension with vasopressors rather than additional fluid boluses. 4
Knowledge Gaps Acknowledged by Guidelines
The guideline authors explicitly identified the need for: 1
- Randomized controlled trials to confirm benefit
- Studies to identify which subgroups benefit most or least from angiography after ROSC
- Evidence in non-VF/pVT rhythms
- Optimal timing of intervention
The American Heart Association 2013 statement specifically noted that "clinical trials are required before practice should change" for the controversial subgroup of patients without ST-elevation. 1